Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Zinc finger protein 789 (ZNF789) is a predicted DNA-binding transcription factor in humans, associated with the C2H2-type zinc finger protein family. Like other zinc finger proteins, ZNF789 is thought to bind specific DNA sequences via its zinc-coordinated finger motifs, thereby regulating gene expression typically by RNA polymerase II. ZNF789 localizes to the nucleoplasm and is predicted to function as a sequence-specific transcriptional regulator. The zinc finger family more broadly is known for regulating diverse cellular processes including transcription, cell cycle control, and DNA repair. While ZNF789 has functional associations with various genes and is linked to certain tumors, its precise biological roles and potential as a therapeutic target remain uncharacterized in the literature.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Zinc finger protein 789 (ZNF789).